“The Middle East” is not one distribution market. Saudi Arabia, the UAE, Egypt and neighboring countries differ in regulation, procurement, pricing, clinical adoption and business culture. Distributor selection must therefore be country-specific.
Begin with product–market fit
Clarify who buys, who influences, how the product is used, whether service or training is required and how pricing compares with established alternatives. This determines whether you need tender access, private-sector reach, a clinical sales team, engineers, educators or a combination.
Compare six dimensions
- Coverage: active reach into the relevant cities, channels and customer groups.
- Category capability: experience with products requiring a similar clinical, technical and commercial approach.
- People: decision-maker commitment and named staff who will own the portfolio.
- Portfolio fit: complementary brands without conflicts that will push your products to the bottom of the priority list.
- Investment capacity: ability to fund registration, stock, demonstrations, training and launch activity.
- Operating discipline: credible forecasting, CRM or pipeline management, reporting and follow-up.
Verify claims through evidence
Ask for team structure, coverage by territory, relevant customers, principal references, launch examples and an initial market plan. Meet more than the owner when possible. The people responsible for regulatory work, sales and clinical support reveal how the business operates day to day.
Evaluate motivation, not only infrastructure
Distributors often express interest because a new portfolio looks attractive. Genuine commitment appears in the quality of questions, speed of follow-up, willingness to assign resources and realism of the proposed plan. A distributor who understands the effort required is more valuable than one offering optimistic forecasts without a route to achieve them.
Align terms with execution
Commercial discussions should cover prices, margins, initial stock, forecasts, samples, training, marketing, regulatory responsibility, territory, exclusivity and review periods. Record who will do what and when. Performance-based milestones provide a clearer foundation than vague promises.
Plan the first 12 months before signing
Agree the registration path, team preparation, target accounts, KOL engagement, launch sequence, customer demonstrations and review rhythm. This exposes gaps early and gives both parties a practical basis for accountability.
Comparing potential Middle East distributors?
Gazika helps manufacturers define the right partner profile, reach decision-makers and assess candidates through a structured regional process.
Discuss your distributor search